Tags Archive Navigation
icon
-
StoryGiving voice to people with a misunderstood disease
-
StoryFacing the fear of breast cancer recurrence
-
StoryShoulder to shoulder
-
StoryQ&A: Addressing unmet needs for people living with PNH, a rare and chronic blood disorder
-
StoryWhen you think of the word ‘cancer’, what are the first words that spring to mind?
-
Media ReleaseNovartis Entresto® granted expanded indication in chronic heart failure by FDA
-
StoryBreaking down barriers for patients with sickle cell disease
-
Featured NewsSound Up for Lung Cancer
-
Media ReleaseAveXis Announces Alignment with FDA on Next Steps Toward a BLA Submission for AVXS-101 in SMA Type 1
-
Media ReleaseAveXis Announces Expanded Clinical Development Program for AVXS-101 in Spinal Muscular Atrophy
-
Media ReleaseAveXis Announces Proposed Public Offering of Common Stock
-
Media ReleaseREGENXBIO and AveXis Announce Expansion of Relationship through Amended License Agreement for the Development and Commercialization of Treatments for Spinal Muscular Atrophy